For the Inventor, By the Inventor

Enter assignee name

Boston, MA, United States of America

The Schepens Eye Research Institute, Inc.

USPTO Granted Patents = 133

% Expired Patents = 7.5

CIPO Patents = 8

EPO Patents = 26

Forward Citations = 1,251

Loading Chart...

Loading Chart...

129 inventors (with patents filed for the assignee):

Luk H Vandenberghe (19 out of 32 patents)

David A Sullivan (17 out of 18 patents)

Eric Zinn (14 out of 14 patents)

4. Reza Dana (13 out of 26 patents)

5. Eliezer Peli (13 out of 19 patents)

6. Benjamin D Sullivan (12 out of 47 patents)

7. Sunil Chauhan (11 out of 11 patents)

8. Tannin Avery Schmidt (9 out of 13 patents)

9. Joseph F Arboleda-Velasquez (7 out of 11 patents)

10. Michael J Young (7 out of 9 patents)

11. Gang Luo (7 out of 11 patents)

12. Dong Feng Chen (7 out of 7 patents)

13. Patricia A D'Amore (6 out of 6 patents)

14. Leo A Kim (6 out of 11 patents)

15. Petr Y Baranov (6 out of 6 patents)

Core Competencies:

Glaucoma Treatment

Retinal Protection

Visual Function Assessment

Adeno-Associated Viruses

Neuroprotection

Dry Eye Disease

Corneal Scarring

Photoreceptor Cells

Ocular Inflammatory Disorders

Ancestral Virus Sequences

Stem Cells

Therapeutics

133 patents: Sort by Forward Citations

1. 12740698 - Predicting clinical parameters relating to glaucoma from central visual field patterns (2026-09-22),

2. 12735725 - ALTERING TISSUE TROPISM OF ADENO-ASSOCIATED VIRUSES (2026-09-15),

3. 12728118 - Methods and compositions for the treatment of corneal endothelium disorders (2026-09-08),

4. 12673063 - Methods and Materials for Treatment of Fibrosis (2026-07-07),

5. 12606802 - Methods and compositions for improving the assembly of adeno-associated viruses (AAVs) (2026-04-21),

6. 12570998 - Methods and compositions for modulating the interaction between adeno-associated virus (AAV) and the AAV receptor (AAVR) for altered bio-distribution of AAV (2026-03-10),

7. 12551100 - Measuring dark adaptation (2026-02-17),

8. 12384834 - Anti-ApoE antibodies and polynucleotides thereof (2025-08-12),

9. 12359174 - Methods of predicting ancestral virus sequences and uses thereof (2025-07-15),

10. 12295985 - Methods of reducing severity of glaucoma by intravitreal administration of insulin-like growth factor binding protein-like 1 (IGFBPL1) (2025-05-13),

11. 12234282 - Therapy for glaucoma and optic neuropathy by targeting colony stimulating factors (2025-02-25),

12. 12227543 - Ancestral virus sequences and uses thereof (2025-02-18),

13. 12226452 - Polyhedrin-based slow release growth factor system for neuroprotection of retinal ganglion cell neurons (2025-02-18),

14. 12226156 - Measuring eye refraction (2025-02-18),

15. 12213732 - Assessing visual function (2025-02-04),

Company Overview

The Schepens Eye Research Institute, Inc., located in Boston, MA, is a leading research organization dedicated to advancing ocular therapeutics. It specializes in innovative treatments for various eye conditions, including glaucoma, dry eye disease, and retinal protection. The institute focuses on core technologies such as neuroprotection and the use of adeno-associated viruses for gene therapy. Its research efforts aim to enhance visual function assessment and address critical issues like corneal scarring and photoreceptor cell health.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

133 Patents

#21 in Boston, MA

#154 in Massachusetts

#2,917 in US

#6,064 in the World

Boston, MA, United States of America

The Schepens Eye Research Institute, Inc.

Forward Citations = 1,251

129 inventors:

Luk H Vandenberghe (19 out of 32 patents)

David A Sullivan (17 out of 18 patents)

Eric Zinn (14 out of 14 patents)

4. Reza Dana (13 out of 26 patents)

5. Eliezer Peli (13 out of 19 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: The Schepens Eye Research Institute, Inc.. Retrieved from https://idiyas.com/company/schepens-eye-research-institute

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…